CompletedInterventionalNot ApplicableUpdated Nov 4, 2016
Long-Term Assessment of Quality of Life and Effectiveness of Onabotulinumtoxina Injections in Provoked Vestibulodynia | NCT02858375 | Trialant
CompletedObservationalUpdated Aug 8, 2016
Long-Term Assessment of Quality of Life and Effectiveness of Onabotulinumtoxina Injections in Provoked Vestibulodynia
ClinicalTrials.gov ID
NCT02858375
Lead Sponsor
Centre Hospitalier Universitaire de BesanconOTHER
Overall Status
Completed
Study Type
Observational
Enrollment
21Actual
Last Update Posted
Aug 8, 2016Estimated
Start Date
Mar 2013
Primary Completion Date
Apr 2013Actual
Completion Date
Apr 2013Actual
Brief Summary
The study aims to assess and compare the pain in women suffering from provoked vestibulodynia, before treatment with botulinum injections, 3 months after treatment and 18 months after treatment.
Vestibulodynia
No interventions
There are no interventions for this study.
Ages Eligible for Study
Adult (18-64)
Sexes Eligible for Study
Female
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Vestibulodynia rated B2 according to 2003 International Society for the Study of Vulvovaginal Disease (ISSVD) classification
Patients previously treated no later than18 months ago for provoked vestibulodynia with botulinum toxin injections, in the University Hospital of Besançon.